ConductScience.org, home

Paper41986366

SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses.

Schmidt SD and 14 others. Nat Commun, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses. Papers, record 41986366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41986366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses.
PubMed
Journal
Nat Commun
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schmidt SDStephen D
2Subramanian RRahul
3Basappa MManjula
4Carroll RRobin
5Rexhepaj MMegi
6Posavad CMChristine M
7Liao JAJeffrey A
8Bohl JAJennifer A
9Chowdhury AAnanda
10Spaulding ABAlicen Bhttps://orcid.org/0000-0002-4687-3259
11Lin BCBob C
12Castro MMikehttps://orcid.org/0000-0002-8045-1754
13Koup RARichard A
14Serebryannyy LALeonid A
15Douek DCDaniel Chttps://orcid.org/0000-0001-5575-8634

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SARS-CoV-2Major topic
Antibodies, NeutralizingMajor topic
COVID-19Major topic
COVID-19 VaccinesMajor topic
Humans
Spike Glycoprotein, Coronavirus
Antibodies, Viral
Vaccination
Angiotensin-Converting Enzyme 2
Neutralization Tests
Animals

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140707428HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptors.Nat Commun2025https://conductscience.org/library/papers/40707428PubMed
232663912An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.N Engl J Med2020https://conductscience.org/library/papers/32663912PubMed
339922192Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses.Cell2025https://conductscience.org/library/papers/39922192PubMed
441345093Molecular insights into species-specific ACE2 recognition of coronavirus HKU5.Nat Commun2025https://conductscience.org/library/papers/41345093PubMed
534623973Cross-protective immunity following coronavirus vaccination and coronavirus infection.J Clin Invest2021https://conductscience.org/library/papers/34623973PubMed
632426212Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.Cell Rep2020https://conductscience.org/library/papers/32426212PubMed
735447072mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.Cell2022https://conductscience.org/library/papers/35447072PubMed
835114688ACE2 binding is an ancestral and evolvable trait of sarbecoviruses.Nature2022https://conductscience.org/library/papers/35114688PubMed
934147139Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses.Cell2021https://conductscience.org/library/papers/34147139PubMed
1041483494Genetic distance predicts neutralizing antibody titers for monovalent and bivalent SARS-CoV-2 vaccines.Vaccine2026https://conductscience.org/library/papers/41483494PubMed
1139532861Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.Nat Commun2024https://conductscience.org/library/papers/39532861PubMed
1241027157SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines.Vaccine2025https://conductscience.org/library/papers/41027157PubMed
1337075127Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.Sci Transl Med2023https://conductscience.org/library/papers/37075127PubMed
1433270381Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.N Engl J Med2021https://conductscience.org/library/papers/33270381PubMed
1536357712Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.Nat Microbiol2022https://conductscience.org/library/papers/36357712PubMed
1639466880Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.PLoS Pathog2024https://conductscience.org/library/papers/39466880PubMed
1734263709Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor.Emerg Microbes Infect2021https://conductscience.org/library/papers/34263709PubMed
1840934083Molecular basis of sarbecovirus evolution and receptor tropism in natural hosts, potential intermediate hosts, and humans.Cell Rep2025https://conductscience.org/library/papers/40934083PubMed
1939402048Sarbecovirus RBD indels and specific residues dictating multi-species ACE2 adaptiveness.Nat Commun2024https://conductscience.org/library/papers/39402048PubMed
2033164751ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.Elife2020https://conductscience.org/library/papers/33164751PubMed

See all 32 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42845495Vaccine imprinting drives increased SARS-CoV-2 variant infection in children.bioRxiv2026https://conductscience.org/library/papers/42845495

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACE259272PubTator's text mininghttps://conductscience.org/library/genes/59272

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41986366

GET https://conductscience.org/api/papers/v1/41986366/references?page=2